Hutchin Hill Capital’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Hutchin Hill Capital’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,984	Closed	-$671K	–	1005
2017 Q2	$671K	Sell	5,984 -9,616	-62%	-$1.09M	0.02%	611
2017 Q1	$1.82M	Sell	15,600 -21,600	-58%	-$2.39M	0.05%	351
2016 Q4	$3.92M	Buy	+37,200	New	+$3.9M	0.14%	192
2016 Q2	–	Sell	-22,000	Closed	-$3.15M	–	758
2016 Q1	$3.15M	Buy	22,000 +2,900	+15%	+$412K	0.09%	253
2015 Q4	$2.95M	Buy	19,100 +2,200	+13%	+$321K	0.07%	240
2015 Q3	$2.42M	Buy	16,900 +5,500	+48%	+$769K	0.09%	272
2015 Q2	$1.64M	Buy	+11,400	New	+$1.63M	0.04%	353
2014 Q3	–	Sell	-10,000	Closed	-$1.4M	–	752
2014 Q2	$1.4M	Hold	10,000	–	–	0.06%	267
2014 Q1	$1.11M	Buy	10,000 +7,400	+285%	+$806K	0.06%	327
2013 Q4	$257K	Sell	2,600 -1,000	-28%	-$86.7K	0.02%	451
2013 Q3	$274K	Buy	+3,600	New	+$234K	0.02%	398

Other funds holding TARO

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Hutchin Hill Capital's TARO Position: Q3 2017 in Review

Hutchin Hill Capital sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2017, closing a stake of 5,984 shares — an estimated $671K sold.

Hutchin Hill Capital first reported a position in TARO in Q3 2013 and held it in 11 quarters. The position peaked at $3.92M in Q4 2016. 133 funds tracked by Wall St. Rank hold TARO as of Q3 2017.

Hutchin Hill Capital reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2017 after selling out during the quarter.
Hutchin Hill Capital sold 5,984 Taro Pharmaceutical Industries Ltd. shares in Q3 2017, an estimated $671K.
Hutchin Hill Capital first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2013 and held it in 11 quarters.
Hutchin Hill Capital's Taro Pharmaceutical Industries Ltd. position peaked at $3.92M in Q4 2016.
133 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.